Patanjali ties up with 1mg to push online sales
The tie up will strategically increase online sales of Patanjali products; expand the reach to customers to end point
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis announces results from CLARITY study
Novartis new data reinforces superiority of Cosentyx versus Stelara in achieving skin clearance for psoriasis patients
PMB growing in Japan and Israel
Mergermarket, an Acuris company, has released full year 2017 Pharma, Medical & Biotech (PMB) report
Dr Reddy’s Q2 Revenues at Rs 35.5 Bn
H1 Revenues at Rs 68.6 Bn, Q2 EBITDA at Rs 6.9 Bn
Sanofi, Regeneron accelerate investment for clinical development
The companies collaborate for the clinical development of PD-1 antibody cemiplimab in oncology and dupilumab in Type 2 allergic…
FDD Leaders Handbook
FDD Leaders Handbook featured the leaders in formulation development and drug delivery who are helming India’s journey to become…
Lynparza approved by US FDA
Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer
Lupin forays into OTC segment
Launches Softovac under the umbrella of Lupin Life Consumer Healthcare
Glenmark initiates Phase IIb dose range finding study
The study will evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritic pain
Intas acquires generics business of Actavis in UK, Ireland
This acquisition is set to more than double Intas' pan-European operations, with pro-forma revenues exceeding $500 million